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Previously, we demonstrated that the phosphorylation of t-SNAREs by protein kinase A (PKA) affects their ability to
participate in SNARE complexes and to confer endocytosis and exocytosis in yeast. Here, we show that the presumed
phosphorylation of a conserved membrane-proximal PKA consensus site (serine-317) in the Sed5 t-SNARE regulates
endoplasmic reticulum (ER)-Golgi transport, as well as Golgi morphology. Sed5 is a phosphoprotein, and both alanine
and aspartate substitutions in serine-317 directly affect intracellular protein trafficking. The aspartate substitution results
in elaboration of the ER, defects in Golgi-ER retrograde transport, an accumulation of small transport vesicles, and the
inhibition of growth of most cell types. In contrast, the alanine substitution has no deleterious effects upon transport and
growth, but results in ordering of the Golgi into a structure reminiscent of mammalian apparatus. This structure seems
to require the recycling of Sed5, because it was found not to occur in sec21-2 cells that are defective in retrograde transport.
Thus, a cycle of Sed5 phosphorylation and dephosphorylation is required for normal t-SNARE function and may
choreograph Golgi ordering and dispersal.
INTRODUCTION
The secretory pathway in eukaryotes consists of distinct
membrane-bound intracellular compartments that transfer
proteins and lipids in bulk from one to the other. This occurs
via transport structures that undergo fusion with subse-
quent compartments. Because these compartments are in a
constant state of flux, due to the continuous exchange of
membrane and protein, obligate protein sorting and re-
trieval mechanisms have evolved to maintain organelle
identity and integrity. Moreover, there is a specific need for
recreating intact and functional organelles after mitosis, via
organelle inheritance and/or biogenesis. The Golgi appara-
tus consists of well-defined subcompartments (cisternae) ar-
ranged in an ordered structure in higher eukaryotes, called
the Golgi stack, which displays an asymmetric distribution
of specific processing enzymes (reviewed in Farquhar and
Palade, 1998). Cargo molecules traverse the stack via the
process of cisternal maturation, which involves the retro-
grade flow of enzymes and transport factors back to earlier
compartments while allowing the cargo to proceed (re-
viewed in Pelham, 1998; Pelham and Rothman, 2000). This
results in steady-state distribution of the protein processing
and delivery factors while allowing cargo to advance and
eventually exit the Golgi via transport vesicles.
The fusion of membranes along the secretory pathway
involves SNAREs, which comprise three main families of
conserved membrane-associated proteins (the VAMP/syn-
aptobrevin, syntaxin, and SNAP-25/light chain families)
that mediate vesicle docking and fusion (reviewed in Chen
and Scheller, 2001). Conventionally, these families fall into
two categories, the v-SNAREs that reside on vesicles and
t-SNAREs that reside on the acceptor compartments. Both v-
and t-SNAREs assemble into a four-helix bundle that
bridges apposed membranes and leads to membrane fusion
(reviewed in Chen and Scheller, 2001). The v-SNARE con-
tributes one -helix to the SNARE complex, whereas three
are contributed by the t-SNAREs. Notably, every intracellu-
lar trafficking step has one syntaxin t-SNARE that serves as
an essential element of the fusion complex. In yeast, the
syntaxin family member, Sed5, plays an essential role in
protein transport from the endoplasmic reticulum (ER) to
the Golgi as well as intra-Golgi transport (Hardwick and
Pelham, 1992, Nichols and Pelham, 1998). Sed5 forms func-
tional SNARE complexes with Sec22, Bet1, and Bos1
(Sogaard et al., 1994; Parlati et al., 2002) to mediate ER–Golgi
transport and with other SNAREs, such as Sft1, Ykt6, Gos1,
and Vti1 to mediate intra-Golgi and endosome-Golgi trans-
port (reviewed by Pelham, 1999). Attempts to systematically
define the number of possible Sed5-containing SNARE com-
plexes revealed that it is promiscuous and forms numerous
complexes in vitro (Tsui et al., 2001); however, only two have
been shown to be functional using an in vitro fusion assay
(Parlati et al., 2002). Nevertheless, the large number of com-
plexes that Sed5 forms in vitro may reflect its importance in
the maintenance of Golgi structure and function.
Sed5 localizes to the cis-Golgi (Hardwick and Pelham
1992) and cycles through the ER (Wooding and Pelham,
1998). However, it is not known how Sed5 is retained at
steady state in the Golgi and what physiological purpose is
served by recycling. In an attempt to define its retention
signal, mutations were made in the transmembrane domain
(TMD), which is known to play a role in the retention of
other SNAREs (Lewis et al., 2000). However, the Sed5 local-
This article was published online ahead of print in MBC in Press
(http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E05–02–0101)
on August 10, 2005.
Address correspondence to: Jeffrey E. Gerst (jeffrey.gerst@
weizmann.ac.il).
4918 © 2005 by The American Society for Cell Biology
ization signal is only partially determined by its TMD (Ban-
field et al., 1994), and thus an additional localization/reten-
tion mechanism exists. In addition to regulating transport to
the Golgi, Sed5 and its orthologues play an important role in
Golgi maintenance and structure. The loss of Sed5 function
is characterized by the accumulation of small transport ves-
icles and an elaboration of ER membranes concomitant with
a decrease in protein transport and cell viability (Hardwick
and Pelham, 1992). ER expansion is indicative of a block in
the exit of proteins from the ER, which may result from an
inhibition in retrograde transport from the Golgi. Interest-
ingly, the overproduction of Sed5 is also inhibitory to cell
growth, resulting in the accumulation of intracellular mem-
branes and secretion of an ER resident protein (Hardwick
and Pelham, 1992). Moreover, Sed5 orthologues have prom-
inent effects upon Golgi structure. For example, the overpro-
duction of Drosophila Sed5 results in the loss of Golgi stacks
in COS cells (Banfield et al., 1994), whereas that of the
NH2-terminal sequence of mammalian Syntaxin-5 disrupts
the Golgi in Vero cells (Yamaguchi et al., 2002).
We have demonstrated a role for t-SNARE phosphoryla-
tion in the regulation of exocytosis and endocytosis in yeast.
Dephosphorylation of the Sso and Tlg t-SNAREs was found
to enhance SNARE assembly and to restore transport in
certain secretory mutants (Marash and Gerst, 2001; Gu-
runathan et al., 2002; Weinberger and Gerst, 2004). In our
studies on the role of signaling cascades in the control of
membrane transport, we have now examined whether Sed5
is controlled by phosphorylation. We found that Sed5 is a
phosphoprotein that harbors a highly conserved PKA phos-
phorylation site proximal to the TMD. Amino acid substitu-
tions in this site, serine-317, have dramatic effects upon
Golgi morphology and function. Expression of pseudophos-
phorylated Sed5, shown using an aspartate substitution,
results in the accumulation of ER and transport vesicles and
an inhibition in cell growth. In contrast, expression of a
nonphosphorylated form of Sed5, using an alanine substi-
tution, results in the accumulation of an ordered Golgi atyp-
ical to Saccharomyces cerevisiae. This structure was absent in
sec21-2 cells, which are defective in Golgi-ER and intra-Golgi
retrograde transport, suggesting a role for Sed5 recycling in
its ability to induce ordered structures. Supportive of this
idea, we found that the nonphosphorylated, but not pseu-
dophosphorylated, form of Sed5 readily entered into trans-
port COPI vesicles. These results suggest that Sed5 phos-
phorylation and dephosphorylation may play a crucial role
in Golgi function and structure. In particular, it may allow
for the Golgi to cycle between ordered and dispersed states,
the latter being important for Golgi inheritance during mi-
tosis (Shorter and Warren, 2002).
MATERIALS AND METHODS
Growth Tests
Yeast were grown in standard amino acid-rich medium (YPD) or selective
synthetic media (SC).
Drop Tests. Cells were grown to log phase in liquid selective medium. Next,
cells were diluted to 106 cells/ml, followed by five serial dilutions of 10-fold
each. Aliquots of the dilutions were applied as drops onto solid media, which
were then incubated at various temperatures.
Yeast Strains
Strains are listed in Table 1.
Plasmids
Constructs for SED5 Expression. SED5 was amplified by PCR using genomic
DNA as a template and primers encoding SalI and SacI sites at the 5 and 3
ends, respectively. The SalI-SacI fragment was inserted in-frame and down-
stream to the hemagglutinin (HA) epitope encoded by vector pAD54 (2,
LEU2), to yield pADH-HASED5. SED5 is under the control of the constitutive
ADH1 promoter. Next, a BamHI fragment containing ADH1-HASED5 was
excised from pADH-HASED5 and cloned into plasmids pRS315 (CEN; LEU2)
to yield pLADH-HASED5, pSE358 (CEN; TRP1) to yield pTADH-HASED5,
and pRS426 (2, URA3) to yield pADHU-HASED5. Point mutations were
made in SED5 to create the alanine-317 and asparate-317 substitutions, by
PCR-based site-directed mutagenesis with PfuI polymerase (Stratagene, La-
Jolla, CA). Multicopy plasmids bearing either LEU2 or URA3 and single-copy
plasmids bearing either LEU2 or TRP1, all of which express SED5, SED5S317A,
or SED5S317D were created. A gene encoding green fluorescent protein (GFP)
was introduced in-frame and upstream to SED5 by subcloning a SalI GFP
fragment into the SalI site of the LEU2 multicopy SED5 plasmids. This created
HA-GFP fusions with SED5, SED5S317A, or SED5S317D. Next, the gene fusions
were excised as BamHI fragments and cloned into the BamHI site of pRS315
to yield the same fusions in single-copy plasmids. Constructs for the integra-
tion of HA-GFP tagged SED5, SED5S317A, or SED5S317D at the native SED5
locus were created by subcloning into plasmid pFA6a-His3MX6 (Longtine et
al., 1998), which encodes a PCR amplification module for integration at target
genes. HindIII and BamHI fragments bearing the different GFP-tagged forms
of SED5 were subcloned from the pAD54 plasmids into plasmid pFA6a-
His3MX6 via the HindIII and BamHI sites. After verification by sequencing,
plasmids were amplified using a 62-bp forward chimeric oligonucleotide
corresponding to the 5 untranslated region of SED5 and downstream HA-
GFP, and a 60-bp reverse oligonucleotide corresponding to the promoter
Table 1. Yeast strains
Name Genotype Source
SP1 MATa ura3 leu2 trp1 ade8 his3 can1 M. Wigler
W303-1b MATa ura3 leu2 trp1 ade2 his3 lys2 can1 J. Hirsch
ise1 MATa his31 leu20 met150 ura30 ise1::kanMX4 EUROSCARF
grh1 MATa his31 leu20 met150 ura30 grh1::kanMX4 EUROSCARF
SP1-SEC7RFP MATa ura3 leu2 ade8 can1 his3 trp1::TRP1::TPI1-DsRed-SEC7 J. Gerst
MLY101 MATa, trp1–1 ufe1::TRP1 his3-200 leu2-3, 112 ura3-52 ufe1::TRP1 pUT1 (CEN6 LEU2 ufe1-1) M. Lewis
CBY265 MATa trp1 ura3 leu2 lys2 sed5-1 C. Barlowe
sed5 MATa ura3::GAL-SED5 sed5::LEU2 trp1-1 D. Banfield
NY1217 MATa ura3-52 leu2-3, 112 sec18-1 P. Novick
RSY1309 MATa ura3-52 leu2-3, 112 lys2-801 suc2-9 sec21-2 A. Spang
RSY324 MATa ura3-52 sec22-2 R. Schekman
RSY641 MATa ura3-52 leu2-3, 112 sec23-2 R. Schekman
RKY1 MATa ura3 leu2 trp1 ade8 sed5::GFP-SED5::his5 can1 This study
RKY2 MATa ura3 leu2 trp1 ade8 sed5::GFP-SED5A317::his5 can1 This study
RKY3 MATa ura3 leu2 trp1 ade8 sed5::GFP-SED5D317::his5 can1 This study
EUROSCARF, European Saccharoymces cerevisiae archive for functional analysis.
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region of the Schizosaccharomyces pombe his5 gene and 3 untranslated region
of SED5. PCR amplified fragments were used to transform SP1 wild-type cells
and were selected for on medium lacking histidine. Integration at the SED5
locus was verified by PCR. A plasmid expressing Sec22-myc-, pWB-GalA,
was provided by H-D. Schmidt (University of Gottingen, Germany).
Metabolic Labeling In Vivo
Protein Phosphorylation In Vivo. Proteins were metabolically labeled in vivo
either with [32P]orthophosphate or [33P]orthophosphate (0.25 and 0.65
mCi/10 O.D.600 U, respectively; GE Healthcare, Piscataway, NJ), essentially
as described previously (Marash and Gerst, 2001).
Pulse-Chase Analysis. Intracellular protein processing was monitored by
pulse-chase analysis using [35S]methionine (GE Healthcare), as described
previously (Couve et al., 1995).
Immunoprecipitation and Subcellular Fractionation
Immunoprecipitation. Coimmunoprecipitation from lysates was performed
as described previously (Marash and Gerst, 2001). When performed in sec18-1
lysates, the cell pellet was first washed with 10 mM NaN3, and both 20 mM
NaF and 1 mM N-ethylmaleimide were added to the lysis buffer. For the
detection of phosphorylated Sed5 in Westerns or by autoradiography, the
lysis buffer was supplemented with the following phosphatase inhibitors: 10
mM NaF, 20 mM NaPPi, 25 mM -glycerophosphate, and 0.5 mM sodium
vanadate. Proteins were detected in immunoblots by chemiluminescence.
Subcellular Fractionation. Yeast were subjected to subcellular fractionation,
as described previously (Lustgarten and Gerst, 1999).
Antibodies
Monoclonal anti-HA antibodies (gift of M. Wigler, Cold Spring Harbor Lab-
oratory, Cold Spring Harbor, NY) were used for both immunoprecipitation
(IP) (1 l) and detection (1:5000). Protein detection in blots was performed
using monoclonal anti-c-myc (1:1000; Santa Cruz Biotechnology, Santa Cruz,
CA) and polyclonal anti-phosphoserine (1:1000; Zymed Laboratories, South
San Francisco, CA), anti-Sed5 (1:3000; gift of H. Pelham, MRC Laboratory for
Molecular Biology, Cambridge, United Kingdom), anti-Bos1 (1:500), anti-Kar2
(1:3000; gifts of C. Barlowe, Dartmouth University, Hanover, NH), anti-Sec22
(1:3000; gift of S. Ferro-Novick, Yale University, New Haven, CT), anti-
Vti1 (1:3000; gift of G. Fischer von Mollard, University of Gottingen); anti-
Emp47 (1:3000; gift of H. Riezman, University of Geneva, Switzerland),
anti-Dpm1 (1:1000; Molecular Probes, Eugene, OR), and anti-Mnn1 antibodies
(1:2000; gift of S. Emr, University of San Diego, San Diego, CA). IP antibodies
for pulse-chase experiments included anti-Gas1 (gift of H. Riezman) and
anti-CPY (gift of S. Emr).
Microscopy
Confocal Microscopy. Cells were grown to log phase and concentrated to 1
O.D.600 U/100 l. Samples were mixed (1:1) with a cooled solution of 2.6%
low melting point agarose in medium and plated on slides. GFP and red
fluorescent protein (RFP; DsRed) fluorescence were visualized using a Radi-
ance 2000 confocal system (Bio-Rad, Hercules, CA).
Immunofluorescence Microscopy. Cells were fixed and permeabilized for
immunofluorescence, as described previously (Lustgarten and Gerst, 1999).
HA-Sed5S317A and HA-GFP-Sed5S317A were labeled with affinity-purified
anti-HA monoclonal antibodies and CY3-conjugated goat anti-mouse anti-
bodies (Jackson ImmunoResearch Laboratories, West Grove, PA).
Electron Microscopy. Cells were concentrated by centrifugation, drawn into
cellulose capillary tubes (200-m inner diameter), and frozen in a Bal-Tec
HPM010 HPF machine. For procedure A, cells were freeze-substituted in a
Leica AFS device in anhydrous acetone containing 0.01% osmium tetroxide
for 3 d at –90°C and then warmed to 0°C over 24 h. Samples were washed two
times with ethanol and infiltrated for 5–7 d at room temperature (RT) in a
series of increasing concentrations of LR-White in ethanol as follows: 5, 10, 30,
50, 60, 80%, and six exchanges of pure resin. After polymerization at 52°C, 60-
to 80-nm sections were stained with uranyl acetate and lead citrate and
examined in an FEI Tecnai T12 electron microscope at 120 kV. Alternatively,
in procedure B, the frozen capillary tubes were freed from extraneous hexa-
decene under liquid nitrogen and freeze-substituted in 2% osmium tetroxide
in anhydrous acetone at –90°C for 32 h, and at –60 and –30°C for 4 h at each
step in a Balzers FSU010 freeze-substitution unit. After washing with acetone,
samples were transferred into an acetone-Epon mixture at 30°C, infiltrated
at RT in Epon, and polymerized at 60°C for 48 h. Ultrathin sections stained
with uranyl acetate and lead citrate were viewed using a Philips CM10
electron microscope at 60 kV.
Golgi Budding Assay
In vitro Golgi budding was performed as described by Spang and Schekman
(1998) with modifications. Enriched Golgi membranes were incubated with
0.1 mM GTP, coatomer (250 g/ml), and Arf1 (80 g/ml) for 30 min at 30°C
in a volume of 200 l. After chilling on ice, samples were loaded on top of a
Ficoll-sucrose gradient consisting of 0.4 ml 60%(wt/wt) sucrose, 0.8 ml 7.5%
(wt/wt) Ficoll, 1 ml of 5% Ficoll, 1 ml of 4% Ficoll, 1 ml of 3% Ficoll, 0.8 ml
of 2% Ficoll in 15% sucrose, 20 mM HEPES, pH 6.8, and 5 mM Mg(OAc)2.
Vesicles were separated from the Golgi by centrifugation for 2 h at 35,000 rpm
(SW55 rotor; Beckman Coulter, Fullerton, CA). Fractions (400 l) were col-
lected from the top of the gradient. Fractions 5–7 were pooled, mixed with an
equal volume of 80% Nycodenz in 20 mM HEPES, pH 6.8, 150 mM KOAc, 5
mM Mg(OAc)2 (B150), and overlaid with 600 l of 30, 25, 20, and 15% and 400
l of 10% Nycodenz in B150. The gradient was centrifuged for 16h at 40,000
rpm (SW55 rotor). Fractions (300 l) were collected from the top, trichloro-
acetic acid precipitated, and analyzed in immunoblots.
RESULTS
Sed5 Is Phosphorylated In Vivo
PKA is involved in the regulation of the Sso and Tlg t-
SNAREs, which confer exo- and endocytic transport in
yeast, respectively (Marash and Gerst, 2001; Gurunathan et
al., 2002). In the case of the Sso t-SNAREs, phosphorylation
inhibits t-t SNARE assembly and recruits a SNARE regula-
tory protein, Vsm1, to the autoinhibitory domain of Sso
(Marash and Gerst, 2001; Marash and Gerst, 2003). Corre-
spondingly, activation of a ceramide-activated protein phos-
phatase (CAPP) reduces Vsm1 binding, restores t-t SNARE
assembly, and confers exocytosis (Marash and Gerst, 2001;
Marash and Gerst, 2003). Because phosphorylation and de-
phosphorylation play a significant role in t-SNARE regula-
tion on the late secretory pathway, we examined whether
ER–Golgi transport is controlled in a similar manner.
We examined whether temperature-sensitive mutations in
SNAREs functioning in the early pathway might be rescued
for growth at restrictive temperatures by the exogenous
addition of C2-ceramide, a CAPP activator, to the medium.
We found that a temperature-sensitive mutation in SED5
(e.g., sed5-1), which encodes an essential Golgi t-SNARE of
the syntaxin family, was partially rescued, whereas muta-
tions in other SNAREs involved in ER–Golgi transport (i.e.,
bos1-1, bet1-1, and sec22-1) were either not affected or were
inhibited (our unpublished data). Thus, Sed5 might be sub-
ject to regulation by phosphorylation.
We noticed two putative PKA phosphorylation sites
present in Sed5: serine-8 and serine-317. The NH2-terminal
phosphorylation site (serine-8) resides proximal to the Habc
domain (Figure 1A), which has a suggested regulatory role
(Yamaguchi et al., 2002). However, alignments of Sed5 or-
thologues revealed that only the COOH-terminal phosphor-
ylation site (serine-317) is highly conserved from yeast to
humans (Figure 1B). This site lies in the region directly
downstream of the SNARE domain (residues 249–311) and
proximal to the TMD (residues 325–339; Hardwick and Pel-
ham, 1992) (Figure 1A).
To demonstrate whether Sed5 is a phosphoprotein, we
first expressed a HA epitope-tagged form of Sed5 in yeast,
performed in vivo labeling with [32P]orthophosphate, and
immunoprecipitated the protein. We examined Sed5 phos-
phorylation in vivo using a number of strains (e.g., WT,
sec18-1, bos1-1). In particular, we found significant incorpo-
ration of labeled phosphate into HA-Sed5 in bos1-1 cells,
which bear a temperature-sensitive t-SNARE involved in
ER–Golgi transport (Figure 1C). We could also demonstrate
phosphorylation on serine residues using an antibody spe-
cific to phosphoserine (Figure 1D). In both experiments, a
single band was observed corresponding to the molecular
mass of HA-Sed5 (42 kDa). Labeling of HA-Sed5 was
A. Weinberger et al.
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found to increase somewhat (30%; n  3) in bos1-1 cells
shifted to the restrictive temperatures (37°C). This increase
may result from the block in SNARE assembly, during
which increased t-SNARE phosphorylation has been docu-
mented previously (Marash and Gerst, 2001).
Because exogenously expressed HA-Sed5 is phosphory-
lated in bos1-1 cells, it was necessary to determine whether
endogenous Sed5 also undergoes phosphorylation. We ex-
amined the phosphorylation of Sed5 expressed from its
genomic locus in wild-type cells using [33P]orthophosphate
and immunoprecipitation with anti-Sed5 antibodies (Figure
1E). In Westerns detected with anti-Sed5, we observed two
Sed5 bands that migrated closely (39 and 41 kDa, respec-
tively); however, autoradiography indicated that only the
higher band incorporated the radiolabel (Figure 1E). Similar
results might have been observed for HA-Sed5 (Figure 1, C
and D), but its overexpression may have impeded resolution
of the two bands that correspond to the phosphorylated and
nonphosphorylated forms. The results obtained from both
bos1-1 and wild-type cells indicate that Sed5 is phosphory-
lated like the Sso and Tlg t-SNAREs (Marash and Gerst,
2001; Gurunathan et al., 2002).
An Aspartate Substitution at Position 317 of Sed5
Inhibits the Growth of Secretory Mutants
To explore the significance of Sed5 phosphorylation in vivo,
we mutated serine-317 by substitution either with alanine to
mimic the nonphosphorylated state or with aspartate to
mimic the phosphorylated state. To verify that serine-317 is
indeed phosphorylated, we immunoprecipitated HA-tagged
Sed5 proteins from wild-type cells using anti-phosphoserine
antibodies. Even though protein expression was similar, we
found a large reduction in the amount of HASed5S317A that
could be precipitated relative to HASed5 (Figure 1F). This is
consistent with the idea that serine-317 undergoes phos-
phorylation in vivo.
Next, we examined the growth of yeast overexpressing
SED5 or the SED5 mutants. We found that both SED5S317A
and SED5S317D were functional in terms of conferring
growth to cells lacking the SED5 gene (Figure 2A). The loss
of Sed5 function is lethal (Hardwick and Pelham, 1992), and
strains expressing a galactose-inducible form of SED5 re-
mained viable on glucose if they expressed native SED5 or
either mutant (Figure 2A). Similar results were observed
with sed5-1 cells, which could be rescued at restrictive tem-
peratures (35°C) by overexpression of either mutant, al-
though SED5S317A expression was less effective in conferring
growth (Figure 2B). Interestingly, we noted that the overex-
pression of SED5 (or SED5S317D) was inhibitory to the
growth of wild-type (WT) yeast, as described previously
(Hardwick and Pelham, 1992). However, this effect was not
observed with SED5S317A.
Because neither substitution inactivates Sed5, we tested
their effects upon yeast defective in protein trafficking to and
from the Golgi (Figure 2C). We examined their effect upon
cells bearing defects in SNAREs required for ER–Golgi
transport (i.e., bos1-1, bet1-1, and sec22-2), a COPII coat com-
ponent required for anterograde transport (i.e., sec23-2), and
a t-SNARE required for retrograde Golgi-ER transport (i.e.,
ufe1-1). We found that mutants overexpressing SED5S317D
were universally inhibited for growth at the semirestrictive
temperature, whereas those expressing SED5S317A often
grew no differently than cells expressing vector alone (Fig-
ure 2C; see bos1-1 and ufe1-1 cells). In no case was the
expression of native SED5 or the mutants able to rescue the
growth of yeast and in several cases (e.g., bos1-1 and ufe1-1
cells), both native SED5 and SED5S317D overexpression had
severe inhibitory effects at normally permissive tempera-
tures. This suggests that overexpression of the pseudophos-
phorylated form (SED5S317D) as well as native SED5, which
can undergo phosphorylation at serine-317, inhibits cell
growth.
It would seem that the nonphosphorylated and pseu-
dophosphorylated forms of Sed5 have very different effects
upon cell growth. The effect upon ufe1-1 cells by SED5S317D
was of particular interest, because Ufe1 functions in retro-
Figure 1. Sed5 is phosphorylated in bos1-1 and wild-type cells. (A)
Schematic of Sed5 structure. A, B, and C, -helices of the putative
autoinhibitory domain; SNARE, SNARE domain; TM, transmem-
brane domain. An arrow marks the location of serine-317. (B) Se-
quence alignment of S. cerevisiae Sed5 with Syntaxin-5 orthologues
from other species. Only the last 36–37 residues of the alignment are
presented. (C) HA-Sed5 is phosphorylated in bos1-1 cells. HA-
tagged Sed5 was expressed from a multicopy vector (pADH-
HASED5) in bos1-1 cells. Cells were harvested in log phase and
labeled with [32P]orthophosphate for 3 h, before being either shifted
to 37°C for 15 min or maintained at 26°C. Cells were lysed in the
presence of phosphatase inhibitors and HA-Sed5 was precipitated
from lysates with anti-HA antibodies. Immunoprecipitated proteins
were detected either in westerns with anti-Sed5 antibodies or by
autoradiography (autoradiogram). Samples of the total cell extract
(TCL) are shown beneath the IP results. (D) HA-Sed5 in bos1-1 cells
is recognized by anti-phosphoserine antibodies. Same as in C, ex-
cept that unlabeled bos1-1 cells were also transformed with a control
plasmid (). Immunoprecipitated proteins were detected in West-
erns with either anti-Sed5 or anti-phosphoserine antibodies. (E)
Endogenous Sed5 is phosphorylated in wild-type cells. Wild-type
(SP1) cells were grown to log phase and labeled with
[33P]orthophosphate for 3 h before lysis and immunoprecipitation
with () or without () anti-Sed5 antibodies (2 l/10 O.D.600 U).
Immunoprecipitated proteins were detected in Westerns with anti-
Sed5 antibodies or by autoradiography (autoradiogram). (F) Serine-
317 is a bona fide phosphorylation site. Wild-type (SP1) cells over-
producing HA-Sed5 or HA-Sed5S317A (plasmids pADH-HASED5 or
pADH-HASED5S317A) were lysed and proteins precipitated using
anti-phosphoserine antibodies (10 l/10 O.D.600 U/reaction) and
detected with anti-HA antibodies in blots. TCL, total cell lysate (50
g of protein).
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grade transport and does not cycle between compartments
like Bos1 and Sec22 (Lewis and Pelham, 1996). Because
ufe1-1 cells are exquisitely sensitive to SED5S317D, but not
SED5S317A, it suggested that phosphorylated Sed5 might
affect retrograde trafficking.
An Aspartate Substitution at Position 317 of Sed5 Induces
Retrograde Trafficking Defects
SED5 was identified as a multicopy suppressor of erd2
cells, which lack the HDEL receptor and thus are unable to
retrieve soluble HDEL-tagged ER resident proteins to the ER
(Semenza et al., 1990; Hardwick and Pelham, 1992). Over-
production of Sed5 in this mutant restored retrograde traf-
ficking back to the ER, possibly due to the enhanced vesic-
ulation of Golgi membranes (Hardwick and Pelham, 1992).
In wild-type cells, however, SED5 overexpression causes
Kar2 (Semenza et al., 1990) to be secreted, perhaps due to
Erd2 depletion within the Golgi (Hardwick and Pelham,
1992). Because the phosphorylation state of Sed5 affects a
strain (ufe1-1) known to be deficient specifically in retro-
grade trafficking (Figure 2C), we looked for further evidence
of retrograde transport defects in WT cells overproducing
Sed5 or the Sed5 mutants (Figure 3). We first examined
whether cells overproducing these proteins secrete Kar2, a
lumenal ER resident protein secreted from yeast bearing
defects in retrograde transport (Semenza et al., 1990) or
retention. We found that cells overexpressing either SED5 or
SED5S317D secreted considerable amounts of Kar2 onto fil-
ters (Figure 3A, left), whereas control cells or cells overex-
pressing SED5S317A secreted little or no Kar2. Because cell
lysis might also account for this phenomenon, we examined
the filters for the presence of cytosolic proteins (e.g., Sec1
and hexokinase). However, we found no evidence to suggest
that cells overexpressing SED5 or SED5S317D are more labile
(Weinberger and Gerst, unpublished observations). More-
over, no difference in Kar2 expression was detected in cells
overexpressing SED5 or the mutants (Weinberger and Gerst,
unpublished observations). Finally, wild-type yeast express-
ing either GFP-SED5 or GFP-SED5S317D from the SED5 locus
were examined for Kar2 secretion (Figure 3A, right). Impor-
tantly, we found that cells expressing GFP-SED5S317D se-
creted Kar2 to a level similar to that of ufe1-1. In contrast,
cells expressing GFP-SED5 (Figure 3A, right) did not secrete
significant amounts of the protein. Thus, an aspartate sub-
stitution at serine-317 alone enhances Kar2 secretion. There-
fore, the lack of Kar2 retention in these cells is independent
of Sed5 overproduction.
Next, we followed processing of the plasma membrane
GPI-anchored protein Gas1. Gas1 undergoes glycosylation
upon arrival to the Golgi, which can be monitored by pulse-
chase analysis and autoradiography. However, defects in
retrograde transport result in an inhibition in Gas1 matura-
tion (Sutterlin et al., 1997). We found that maturation was
severely inhibited in cells overexpressing SED5 or
SED5S317D (Figure 3B), and only a small amount of mature
Gas1 became visible after 45 min of chase. In addition, a
low-molecular-weight form (50 kDa) of Gas1, which may
represent a cleavage product, accumulated in a similar time-
dependent manner. In contrast, mature Gas1 was readily
visible within 5–10 min of chase in cells overexpressing
SED5S317A as well as in control cells. In these cells, no
low-molecular-weight form was observed at50 kDa. Thus,
Gas1 maturation seems defective in cells overexpressing
SED5 or SED5S317D.
The processing of the vacuolar protease carboxypeptidase
Y (CPY) is used to examine anterograde transport along the
secretory pathway. The p1CPY precursor is synthesized in
the ER, modified in the Golgi to the larger p2CPY form, and
is transported to the vacuole were it is cleaved to yield the
mature form (Stevens et al., 1982). We examined CPY pro-
Figure 2. Effect of alanine and asparate substitutions at position
317 in Sed5 on the growth of early secretory mutants. (A) Sed5
mutants rescue sed5 cells. sed5 cells bearing a galactose-inducible
SED5 were transformed with single-copy plasmids expressing
SED5, SED5S317A, and SED5S317D (plasmids pTADH-HASED5,
pTADH-HASED5S317A, and pTADH-HASED5S317D, respectively).
Cells were grown on galactose-containing medium to ensure SED5
expression and then either shifted to glucose-containing medium
overnight or maintained on galactose, before serial dilution and
plating. Control, cells transformed with a control plasmid. Cells
were grown on plates for 2 days. (B) Sed5 mutants rescue sed5-1
cells. SED5, SED5S317A, and SED5S317D were expressed from multi-
copy plasmids (plasmids pADH-HASED5, pADH-HASED5S317A,
and pADH-HASED5S317D, respectively) in either WT or sed5-1 tem-
perature-sensitive cells. Cells were grown on glucose-containing
medium, diluted and plated, and grown as described in A at 26 and
35°C. The plated wild-type transformants were grown for 36 h,
whereas the sed5-1 transformants were grown for 48 h. (C) SED5,
SED5S317A, and SED5S317D were expressed from multicopy plasmids
in the temperature-sensitive mutants listed. Plasmids used to trans-
form bos1-1, sec22-2, and sec23-2 cells are as listed in B, whereas
plasmids pADHU-HASED5, pADHU-HASED5S317A, and pADHU-
HASED5S317D were used for ufe1-1 cells. Cells were grown at per-
missive temperatures (26°C), diluted and plated, and grown at
either permissive (26°C) or semirestrictive temperatures (32–35°C),
which varied from strain to strain.
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cessing in WT cells overexpressing SED5 or the mutants by
pulse-chase analysis. Unlike Gas1 processing, however, we
found that CPY processing and maturation was only slightly
delayed in cells expressing SED5 or SED5S317D (Weinberger
and Gerst, unpublished observations). mCPY was observed
within 30 min or less in all cell types; thus, the inhibition of
transport exerted by SED5S317D and native SED5 overex-
pression seems specific to certain cargo. This may explain
why cells overproducing these proteins are growth inhibited
but are not inviable (Figure 2). Because at least two classes of
COPII vesicles mediate ER–Golgi transport (Muniz et al.,
2001), it is possible that biogenesis or trafficking of the
Gas1-containing class is more strongly influenced by Sed5
phosphorylation.
As anterograde transport of CPY is unaffected by SED5
overexpression, we looked for additional retrograde trans-
port defects. We used a Sec22-myc--factor (Sec22-) re-
porter, which contains a Kex2 cleavage site downstream of
the myc epitope (Ballensiefen et al., 1998). Cells defective in
retrograde transport (i.e., sec21-1 and ufe1-1) fail to retrieve
Sec22- to the ER, resulting in Kex2-dependent cleavage
upon reaching the trans-Golgi and subsequent degradation
in the vacuole (Ballensiefen et al., 1998). We followed the rate
of disappearance of Sec22- and its cleavage product in WT
cells expressing SED5 or the mutants (Figure 3C). Sec22-
was first expressed under the control of a GAL promoter
overnight and then “chased” by transferring the culture to
glucose-containing medium for up to 2 h. Rapid cleavage of
Sec22- was observed in cells overproducing Sed5 or
Sed5S317D and within 1 h even the full-length protein disap-
peared. However, in control cells and more so in cells ex-
pressing Sed5S317A, both the full-length protein and the Kex2
cleavage product were observed for up to 2 h. Quantification
revealed that 12.3 and 7.2% of the initial Sec22- signal
remained after 1 h in control and SED5S317A-expressing cells,
respectively. In contrast, cells overexpressing SED5 or
SED5S317D showed only 0.5 and 1.1% of their initial signal.
This makes it likely that Sec22- retrieval to the ER is inhib-
ited only in cells expressing a phosphorylatable form of
Sed5. We note that Sec22- undergoes degradation even in
control cells, because its overexpression probably saturates
the basal retrieval machinery (Ballensiefen et al., 1998). Thus,
from three independent assays we can see severe defects in
retrograde transport from the Golgi to the ER, which are
inflicted upon SED5 overexpression and sustained by the
phospho-mimetic form SED5S317D. In contrast, cells express-
ing the nonphosphorylated form of Sed5 at position 317
have no such defects.
The cells were grown to log phase on galactose-containing medium
and transferred to glucose-containing medium. Aliquots were re-
moved at the indicated times, lysed, and subjected to Western
analysis. Sec22-myc--factor (Sec22-myc-) and Sec22-myc were de-
tected using anti-myc antibodies, whereas Sed5 was detected using
anti-HA antibodies. (D) Sed5 mutants form complexes with ER–
Golgi SNAREs to the same extent as native Sed5. sec18-1 cells
expressing HA-tagged SED5 (SED5), SED5S317A (S317A) or
SED5S317D (S317D) from single copy plasmids (pLADH-HASED5,
pLADH-HASED5S317A, and pLADH-HASED5S317D) were grown to
log phase and either maintained at the permissive temperature
(26°C) or shifted to the restrictive temperature (37°C) for 15 min,
before processing for coimmunoprecipitation. Proteins were immu-
noprecipitated using anti-HA antibodies and detected in immuno-
blots with antibodies against Sed5, Bos1, Vti1, and Sec22. TCL, total
cell lysate was detected with anti-Sed5 antibodies to demonstrate
presence of HA-tagged and endogenous Sed5.
Figure 3. Overexpression of Sed5 or Sed5S317D inhibits Golgi–ER
retrograde transport. (A) Secretion of Kar2. Left, control (ufe1-1 and
bet1-1) and wild-type (SP1) cells expressing SED5, SED5S317A, and
SED5S317D from multicopy plasmids (pADHU-HASED5, pADHU-
HASED5S317A, and pADHU-HASED5S317D) were grown on syn-
thetic medium at 26°C, replica-plated onto nitrocellulose filters
(BA-S 85; Whatman Schleicher and Schuell, Dassel, Germany), and
grown for 24 h. Next, cells were washed off and the filters detected
for secreted Kar2, using anti-Kar2 antibodies. Right, WT (SP1) cells
bearing integrated (int) forms of GFP-tagged SED5 and SED5S317D
(RKY1 and RKY3 cells, respectively), and control ufe1-1 cells were
grown at 26°C, replica plated onto filters, and grown before detec-
tion with anti-Kar2 antibodies, as described above. (B) Gas1 pro-
cessing. WT cells expressing SED5, SED5S317A, and SED5S317D from
multicopy plasmids (pADH-HASED5, pADH-HASED5S317A, and
pADH-HASED5S317D) were pulse-labeled with [35S]methionine for 3
min, and samples were taken at the indicated time points of the
chase. Gas1 was precipitated from lysates using anti-Gas1 antibod-
ies, resolved by SDS-PAGE, and detected by autoradiography. An
asterisk indicates a cleavage product at 50 kDa. (C) Sec22-myc--
factor processing in cells overexpressing Sed5 mutants. Cells over-
expressing SED5, SED5S317A, or SED5S317D (plasmids pADH-
HASED5, pADH-HASED5S317A, and pADH-HASED5S317D,
respectively) were transformed with a plasmid expressing the
Sec22-myc--factor fusion under a galactose-inducible promoter.
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Sed5S317A and Sed5S317D Assemble into SNARE Complexes
Because the phenotype of SED5 overexpression is abrogated
by mutating serine-317 to alanine, we speculated that the
mutant might be unstable and undergo degradation. This
alone could prevent the defects in retrograde transport ob-
served upon native SED5 overexpression. To test this, we
performed pulse-chase analysis with [35S]methionine and
immunoprecipitated Sed5 proteins. However, we found that
Sed5S317A was no less stable than native Sed5 for up to 60
min and beyond (Weinberger and Gerst, unpublished ob-
servations).
An alternative explanation for the absence of an effect by
Sed5S317A on retrograde transport is an inability of the mu-
tant to enter into SNARE complexes. To test this, we exam-
ined the ability of Sed5 and Sed5 mutants to interact with
SNAREs in vivo by coimmunoprecipitation. We expressed
HA-tagged Sed5 and the mutants from single-copy plasmids
in sec18-1 temperature-sensitive cells, which accumulate
SNARE complexes at restrictive temperatures (Sogaard et al.,
1994). We followed the coprecipitation of SNAREs involved
in ER–Golgi transport (i.e., Bos1, Sec22, and Bet1), intra-
Golgi and endosomal sorting (i.e., Vti1) that are known to
form complexes with Sed5 (Sogaard et al., 1994; Fischer von
Mollard et al., 1997; Lupashin et al., 1997; Tsui et al., 2001;
Parlati et al., 2002). We found that the ability of Sed5S317A to
bind to Bos1, Sec22, Bet1, Ykt6, and Vti1 was similar to that
of Sed5 and Sed5S317D (Figure 3D; Weinberger and Gerst,
unpublished observations). This implies that transport de-
fects elicited by the alanine or aspartate substitutions are
probably not mediated by changes in SNARE pairing per se.
GFP-Sed5S317A Labels an Exaggerated Brefeldin A
(BFA)-dissociable Compartment
Because serine-317 is proximal to the TMD of Sed5 and
given that Sed5 cycles between the ER and Golgi (Wooding
and Pelham, 1998), it is possible that this residue could
regulate Sed5 localization. To examine this, we generated
GFP-Sed5 chimeras using native Sed5 and both the alanine
and aspartate substitution mutants to follow their localiza-
tion in vivo by fluorescence microscopy. All three GFP-Sed5
chimeras exerted similar effects as their nonchimeric Sed5
counterparts, when expressed in sed5-1 temperature-sensi-
tive yeast (our unpublished data). Both GFP-Sed5 and GFP-
Sed5S317D had a random punctate distribution, typical of
yeast Golgi markers (Figure 4A). Surprisingly, GFP-
Sed5S317A was distributed differently, occurring in large ag-
gregates that are predominantly adjacent to the bud neck in
wild-type cells. This was observed using both multicopy and
single-copy expression plasmids as well as by genomic in-
tegration of GFP-SED5S317A at the SED5 locus (Figure 4A)
and was reconfirmed by immunofluorescence studies using
antibodies against HA-tagged Sed5S317A lacking the GFP
fusion (Figure 4B).
Next, we verified that GFP-Sed5S317A labels Golgi mem-
branes and is not mislocalized to other cellular compart-
ments. We examined GFP-Sed5S317A labeling in erg6/ise1
Figure 4. Sed5S317A localizes to an enlarged Golgi compartment.
(A) Localization of GFP-Sed5 and GFP-Sed5 mutants in WT cells.
WT (SP1) cells were transformed either with multicopy (pAD54
based: pADH-HAGFPSED5, pADH-HAGFP-SED5S317A, or pADH-
HAGFP-SED5S317D) or single-copy (pRS315 based: pLADH-HAGF-
PSED5, pLADH-HAGFP-SED5S317A, or pLADH-HAGFP-
SED5S317D) plasmids that express GFP-SED5, GFP-SED5S317A, or
GFP-SED5S317D or with constructs that result in the integration of
either GFP-SED5, GFP-SED5S317A, or GFP-SED5S317D at the genomic
SED5 locus. The latter gene fusions are under the control of the
endogenous SED5 promoter. Cells were grown to log phase, and
samples were taken for confocal microscopy. (B) Sed5S317A labeling
is identical to that of GFP-Sed5S317A, as shown by immunofluores-
cence. WT cells overexpressing HA-tagged Sed5S317A or HA-tagged
GFP-Sed5S317A were grown to log phase, fixed for immunofluores-
cence, and visualized using affinity-purified anti-HA antibodies and
fluorescence microscopy. (C) BFA induces the dispersal of the GFP-
Sed5S317A labeled compartment and redistribution to the ER. ise1
cells transformed with a multicopy plasmid (pADH-
HAGFPSED5S317A) expressing GFP-SED5S317A were grown to log
phase, incubated either with 100 g/ml BFA (BFA) in medium or
with medium alone (BFA) for 15 min, and visualized by fluores-
cence microscopy. (D) GFP-Sed5S317A colocalizes with a trans-Golgi
marker, Sec7-RFP. WT cells containing an integrated copy of SEC7-
dsRED (SEC7-RFP) were transformed with multicopy plasmids ex-
pressing GFP-SED5, GFP-SED5S317A, or GFP-SED5S317D (plasmids
pADH-HAGFPSED5, pADH-HAGFP-SED5S317A, or pADH-
HAGFP-SED5S317D). Cells were grown to log phase and visualized
by fluorescence microscopy. Merge shows the overlap between
GFP-Sed5 and Sec7-RFP.
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cells that are permeable and sensitive to BFA, a fungal
inhibitor that induces disassembly of the Golgi (Vogel et al.,
1993; Chardin and McCormick, 1999). Surprisingly, we were
unable to transform erg6/ise1 cells with plasmids expressing
GFP-SED5 or GFP-SED5S317D (our unpublished data) but
were able to express GFP-SED5S317A. GFP-Sed5S317A label-
ing in this strain (Figure 4C, left) was similar to that seen in
WT cells (Figure 4, A and B) and could be dispersed to the
ER by treatment of the cells with BFA for 15 min (Figure 4C,
right). Thus, the large compartments labeled by GFP-Sed5
S317A seem to represent an exaggerated Golgi apparatus.
GFP-Sed5S317A Colocalizes with a trans-Golgi Marker
Because Sed5 is a cis-Golgi protein (Banfield et al., 1994), we
examined whether GFP-Sed5S317A colocalizes with late
Golgi markers in the enlarged Golgi compartment. We ex-
amined colocalization with a RFP-tagged form of Sec7, a
trans-Golgi marker (Franzusoff et al., 1991). In the case of
GFP-Sed5 and GFP-Sed5S317D, there was little colocalization
observed with RFP-Sec7; however, in cells expressing
Sed5S317A full colocalization was evident (Figure 4D). This
suggested either that the cis- and trans-markers are mixed in
cells expressing Sed5S317A or that the membranes bearing
these fluorescent-tagged proteins are tightly juxtaposed.
GFP-Sed5S317A Expression Results in a Stacked
Mammalian-like Golgi, Whereas GFP-Sed5S317D
Expression Results in Vesiculation and ER Elaboration
To examine the intracellular morphology of cells overpro-
ducing Sed5 and the Sed5 mutants, we used electron mi-
croscopy. We overexpressed SED5, SED5S317D, and
SED5S317A in WT cells and performed rapid fixation using
high-pressure freezing (HPF). Interestingly, the overexpres-
sion of SED5 and SED5S317D led to cells having abundant
and elaborated ER membranes distributed throughout the
cytoplasm (Figure 5, B and E). In addition, clusters of small
vesicles (40–50 nm) were readily apparent in cells overex-
pressing SED5S317D (Figure 5E). Notably, similar clusters
have been shown in cells depleted of Sed5 (Hardwick and
Pelham, 1992).
Figure 5. Sed5S317A overexpression leads to an ordered Golgi stack, whereas Sed5S317D overexpression induces ER elaboration and vesicle
accumulation. HA-tagged SED5, SED5S317A, and SED5S317D were overexpressed from multicopy plasmids (pADH-HASED5, pADH-
HASED5S317A, and pADH-HASED5S317D) in WT cells. Cells were harvested in log phase, fixed by HPF, and visualized by thin sectioning and
electron microscopy. (A) Control WT cell. (B) Cell overexpressing SED5. Black arrowheads indicate elaborated ER. (C) Cell overexpressing
SED5S317A. White arrowhead indicates stacked Golgi-like structure. Inset shows example of ordered Golgi from a different cell. (D)
Immunogold labeling of a cell overexpressing SED5S317A. White arrowheads indicate ordered Golgi. Inset shows magnification of one stack;
note the presence of gold particles indicating the localization of HA-tagged Sed5S317A within the stack. (E) Cells overexpressing SED5S317D.
Black arrowheads indicate ER elaboration. White arrowheads indicate clusters of small vesicles. Top left, cell prepared by HPF using
procedure B; bottom left, magnification of the same cell. Bottom right, example of vesicle cluster from a different cell; top right, example of
cell fixed by HPF using procedure A. Bars, 0.2 m.
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More surprisingly, overexpression of SED5S317A resulted
in the appearance of stacked membranes reminiscent of the
Golgi observed in higher eukaryotes (Figure 5, C and D).
Immunogold staining of these thin sections using antibodies
against the HA-tagged protein revealed the presence of
Sed5S317A within the stacks (Figure 5D). Thus, expression of
both the nonphosphorylated and pseudophosphorylated
forms of Sed5 has dramatic effects upon intracellular mor-
phology in yeast.
Golgi Stacking Does Not Change the Distribution of Golgi
Markers
To determine whether the structural changes elicited by the
two forms of Sed5 alter protein distribution throughout the
endomembrane system, we examined the effects of
Sed5S317A and Sed5S317D expression by crude subcellular
fractionation. We expressed HA-tagged forms of Sed5 and
the mutants in WT cells and prepared two membrane frac-
tions: a medium-speed pellet (P10) that is thought to contain
the majority of the ER membranes and a high-speed pellet
(P100) that includes the bulk of Golgi membranes. We then
examined the distribution of various proteins, including
Emp47, which localizes at steady state to the cis-Golgi, but
recycles between the ER and Golgi (Lewis and Pelham, 1996)
like Sed5 (Wooding and Pelham, 1998). We also examined
the distribution of a medial-Golgi marker, Mnn1, and an ER
marker, Dpm1. First, we noticed that native Sed5 localized
to the P10 fraction, along with Dpm1, implying that the
t-SNARE associates either with an ER-associated structure,
perhaps the transitional ER, or that the cis-Golgi sedimented
in this fraction (Figure 6A). Next, we found that the over-
produced HA-tagged Sed5 and Sed5S317D proteins were also
mainly in the P10 fraction, unlike HA-tagged Sed5S317A,
which was evenly divided between the P10 and P100 frac-
tions (Figure 6A). Emp47 and Mnn1 distributed primarily to
the P10 fraction in cells overexpressing SED5 and
SED5S317D, unlike in control cells or cells expressing
SED5S317A where the Golgi markers were present in both the
P10 and P100 (Figure 6A). Thus, cells bearing the nonphos-
phorylated form of Sed5, which seem to have an ordered
Golgi (Figure 5), show no alteration in the distribution of
Golgi markers vis a` vis control cells expressing SED5 at
native levels. In contrast, the redistribution of Golgi markers
to the P10 fraction in cells overproducing either native Sed5
or its pseudophosphorylated form implies that t-SNARE
phosphorylation can alter Golgi constituency.
The Nonphosphorylated Form of Sed5 Efficiently
Incorporates into COPI Vesicles
Because Sed5S317D overproduction inhibits retrograde trans-
port and induces elaboration of the ER and the accumulation
of vesicles, we examined its ability to enter into Golgi-
derived COPI-coated vesicles thought to mediate retrograde
transport. We used an in vitro Golgi budding assay (Spang
and Schekman, 1998) to generate COPI vesicles in the pres-
ence of Arf1, GTP, and coatomer. COPI vesicles were gen-
erated from isolated Golgi and were fractionated by density
gradient centrifugation (Figure 6B). Although Sed5S317A was
efficiently incorporated into vesicles along with Emp47, both
Sed5 and Sed5S317D were far less able to undergo packaging
therein. This suggests that nonphosphorylated Sed5 may be
better recruited into COPI vesicles and thus may undergo
more efficient retrieval (either to the ER, within the Golgi, or
both) in contrast to either the pseudophosphorylated or
phosphorylatable forms of the t-SNARE.
Figure 6. SED5 and SED5S317D overexpression induces the redis-
tribution of Golgi markers, but they themselves are retained in the
Golgi. (A) SED5 and SED5S317D overexpression redistributes Golgi
markers. HA-tagged Sed5, Sed5S317A and Sed5S317D were overpro-
duced in WT cells from multicopy plasmids (pADH-HASED5,
pADH-HASED5S317A, and pADH-HASED5S317D, respectively).
Cells were lysed in a detergent-free buffer, and the lysates were
subjected to differential centrifugation to obtain a medium-speed
pellet (P10) and high-speed pellet (P100) (10,000 and 100,000  g,
respectively). Samples of equal volume from the fractions were
solubilized with SDS (1% final concentration); resolved by SDS-
PAGE; and detected in blots using anti-Mnn1, anti-Emp47, anti-
Dpm1, and anti-HA antibodies. (B) Sed5S317A is efficiently incorpo-
rated into COPI vesicles. Cells overproducing HA-tagged Sed5,
Sed5S317A, and Sed5S317D were grown to log phase; lysed in the
absence of detergent; and a Golgi-enriched fraction prepared by
differential centrifugation. The formation of COPI-coated vesicles
was induced by the addition of purified coatomer, Arf1, ATP, and
GTP. Vesicles were fractionated by density gradient centrifugation,
and samples from the fractions were precipitated, resolved by SDS-
PAGE, and detected in blots using anti-Sed5 and anti-Emp47 anti-
bodies. Ctrl-Golgi, a sample (30 g) of the Golgi membranes used as
the source for vesicles.
A. Weinberger et al.
Molecular Biology of the Cell4926
Formation of Ordered Golgi Structures Requires Golgi-ER
Retrograde Transport but Not the Yeast GRASP65
Homolog
Because Sed5S317A induces the formation of an enlarged and
ordered Golgi (Figures 4 and 5) and is readily able to enter
into COPI vesicles unlike Sed5 and Sed5S317D (Figure 6), it
suggested that the ability of Sed5 to recycle, either to the ER
or within the Golgi, might be an important influence upon
Golgi morphology. To test this, we examined whether or-
dered structures could be observed in yeast defective in
retrograde Golgi-ER transport. We examined the localiza-
tion of GFP-Sed5S317A in sec21-2 cells, which are defective in
COPI-mediated retrograde transport at restrictive tempera-
tures (Figure 7). Interestingly, we were unable to find the
enlarged Golgi aggregates typically observed in cells over-
producing GFP-Sed5S317A at any temperature (Figure 4).
Instead, the labeling of GFP-Sed5S317A in sec21-2 cells (Figure
7) was similar to that observed for GFP-Sed5 in wild-type
cells (Figure 4); 92% of cells (n  100) expressing GFP-
Sed5S317A did not show Golgi aggregates. In contrast, the
enlarged Golgi puncta were readily observed in sec23-2 cells,
which bear defects in anterograde ER–Golgi transport, at
permissive temperatures, whereas labeling of the ER was
observed at the restrictive temperature, as expected (Figure
7). Thus, Sed5 recycling is likely to be important for the
formation of ordered Golgi structures.
Next, we examined whether the yeast orthologue of
GRASP65, a protein known to function in the postmitotic
reassembly of the Golgi in mammalian cells (Shorter and
Warren, 2002), is necessary for formation of an ordered
Golgi. We overproduced GFP-Sed5S317A in cells lacking
GRH1, but we found no obvious defects in formation of the
fluorescent puncta (Figure 7). This suggests that this ortho-
logue is not necessary for Golgi stacking per se
DISCUSSION
Because t-SNARE phosphorylation and dephosphorylation
seem to play a significant role in regulation of the exo- and
endocytic processes (Weinberger and Gerst, 2004), we exam-
ined whether ER–Golgi transport is controlled in a similar
manner. Here, we show that an essential Golgi t-SNARE,
Sed5, is a phosphoprotein and that phosphorylation controls
the morphology and apparent functioning of the Golgi ap-
paratus. Sed5 overproduction inhibits the growth of yeast
(Hardwick and Pelham, 1992; Figure 2), which is recapitu-
lated in an even stronger manner by the replacement of a
conserved serine residue (serine-317) with aspartate (Figure
2, B and C). In contrast, this phenotype is abrogated by
introduction of an alanine residue in place of the relevant
serine (Figure 2, B and C). Thus, both phosphorylation and
dephosphorylation of this residue seem to play a critical role
in Sed5 functioning.
Although both the aspartate and alanine substitutions
confer growth to yeast lacking a functional Sed5 (Figure 2),
the aspartate-317 substitution results in a marked decrease
in the growth of bos1-1, sec23-2, and ufe1-1 cells (Figure 2C).
However, only ufe1-1 cells are specifically defective in Gol-
gi–ER retrograde transport (Lewis and Pelham, 1996). Other
postulated retrograde transport defects, such as Kar2 secre-
tion, an inhibition of Gas1 processing, and the pronounced
degradation of a Sec22--factor chimeric protein, were all
observed in wild-type cells expressing SED5S317D (Figure 3).
Similar results were obtained with overproduced native
Sed5, which can undergo phosphorylation, but not with the
nonphosphorylatable alanine substitution at position-317
(Figure 3). Importantly, these transport defects are not con-
sistent with a general deficiency in protein export from
either the ER or the Golgi. For example, Kar2 and Sec22--
factor either reach post-Golgi compartments or are exported
(Figure 3, A and C). Next, GFP-Sed5 and GFP-Sed5S317D give
punctate labeling that is typical of the Golgi and not the ER
(Figure 4A), indicating that they can exit early compart-
ments. Finally, CPY maturation is not blocked in cells over-
expressing Sed5S317D (Weinberger and Gerst, unpublished
observations). Although Gas1 maturation does seem inhib-
ited (Figure 3B), this export defect has also been shown in
cells defective in retrograde transport (Sutterlin et al., 1997).
Thus, our observations implicate serine-317 phosphoryla-
tion as a potential regulator of Golgi–ER retrograde trans-
port.
Supportive of this view is electron microscopy data show-
ing ER elaboration and the accumulation of small clustered
transport vesicles in cells expressing the aspartate-317 sub-
stitution (Figure 5E). Because a similar phenotype was ob-
served in cells lacking Sed5 (Hardwick and Pelham, 1992), it
suggests that constitutive phosphorylation of serine-317 can
have an effect analogous to decreased Sed5 function in some
assays. However, the overexpression of native SED5 also
inhibited cell growth (Figure 2C) and induced both retro-
grade sorting defects and ER elaboration (Figures 3, A–C,
and 5) as well as SED5S317D, but it could not induce vesicle
accumulation (Figure 5). Thus, although the phospho-mi-
Figure 7. Retrograde Golgi–ER transport is required for formation
of the enlarged Golgi compartment. Yeast strains (sec21-2, sec23-2,
and grh1) were transformed with a plasmid overexpressing GFP-
SED5S317A (pADH-HAGFPSED5S317A) and examined by confocal
fluorescence microscopy. Cells were examined at a temperature
permissive for growth (26°C) or were shifted to the restrictive
temperature (37°C), before examination.
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metic mutant is clearly functional (Figures 2A and 3D), it can
exert effects unlike that those of the native t-SNARE. Thus,
the effects of SED5 and SED5S317D overexpression are com-
parable but not necessarily identical. This may explain why
the aspartate substitution mutant is more potent in some
assays (Figures 2C, 3A, and 5). Although the mechanism for
vesicle accumulation in cells expressing SED5S317D is un-
clear, it suggests defects in either the fusion of Golgi-derived
COPI vesicles with the ER or COPII vesicles with the Golgi.
The former possibility is more likely, because defects in
retrograde transport invariably block the budding of ER-
derived transport vesicles and lead to the accumulation of
ER membrane. More work will be required to verify the
nature of these vesicles.
If the vesicles observed in SED5S317D-expressing cells are
indeed retrograde transport vesicles, why should they be
less able to fuse? The answer may lie with the fact that
Sed5S317D and phosphorylatable native Sed5 inefficiently in-
corporate into Golgi-derived COPI vesicles in vitro (Figure
6B). Perhaps Sed5 is required for trans-SNARE pairing with
ER resident SNAREs (i.e., Ufe1, Sec20, and Sec22) to form a
retrograde fusion complex. Alternatively, it may be needed
to chaperone cycling SNAREs (i.e., Bos1, Bet1, and Sec22) or
other factors back to the ER. In either case, it would explain
why Sed5 cycles between compartments (Wooding and Pel-
ham, 1998). Another possibility is that the phosphorylated
form of Sed5 binds to Arf GTPases less well, thus decreasing
the formation of retrograde transport vesicles. However, this
possibility is less likely, given that such vesicles can be
formed in the presence of Sed5S317D (Figure 6B) and that in
vitro binding studies with the Sed5 mutants and recombi-
nant myristoylated Arf1 showed no difference in Arf bind-
ing (Spang, unpublished observations). Fractionation exper-
iments suggest that the constituency of the Golgi may
change upon SED5 or SED5 S317D overexpression and that a
redistribution of Golgi markers to a heavier ER-enriched
fraction occurs (Figure 6A). Ironically, this happens even
though Sed5S317D (or native Sed5) does not efficiently enter
into COPI vesicles in vitro like Sed5S317A (Figure 6B). Be-
cause GFP-Sed5S317D does not yield ER-like labeling (Figure
4D), it is unlikely that it associates with ER membranes and
presumably is associated with the early Golgi. More work
will be required to understand the connection between al-
tered Sed5 recruitment into COPI vesicles and the redistri-
bution of the Golgi markers.
Our other major observation is that the nonphosphory-
lated form of Sed5, Sed5S317A, results in the accumulation of
an ordered Golgi reminiscent of the stacked apparatus
found in higher eukaryotes (Figure 5, C and D). Although
cells expressing Sed5S317A show no defects in protein traf-
ficking or growth (Figure 2); nonetheless, the dispersed
Golgi typical of S. cerevisiae seems absent. Thus, formation of
an ordered Golgi from a disordered state seems to have no
debilitating effects upon the growth of yeast per se. Indeed,
other yeast, such as Pichia pastoris, favor an ordered state
(Glick, 1996). The differences between these yeast are
thought to result from the number of sites available for
COPII vesicle budding, which bud from fixed sites in P.
pastoris and throughout the ER in S. cerevisiae (Rossanese et
al., 1999). This may be responsible for the formation of either
polarized or scattered transitional ER, respectively, which
eventually coalesce to form the Golgi (Rossanese et al., 1999).
Our results imply that a lack of phosphorylation at position
317 of Sed5 induces an ordered state of the Golgi (Figure 5,
C and D, and model in Figure 8). In contrast, pseudophos-
phorylation induces a dispersed state, if the vesicles that
accumulate therein are COPI vesicles (Figure 5E and model
in Figure 8). Thus, a dynamic cycle of t-SNARE phosphor-
ylation and dephosphorylation may be necessary for the
Golgi to maintain structural integrity even in S. cerevisiae.
Changes in the ability of Sed5 to cycle (via phosphorylative
control) can also be expected to play a role in the de novo
formation of the early Golgi from the transitional ER (Ros-
sanese et al., 2001).
How can the phosphorylation state of a SNARE influence
organelle integrity so dramatically? One clue is that Sed5
acts upon multiple Golgi transport pathways, including an-
terograde transport to the cis-Golgi (using the Bos1, Bet1,
and Sec22 SNAREs), intra-Golgi transport (using the Sft1,
Got1, and Ykt6 SNAREs) as well as endosome-to-Golgi
transport (using Tlg1, Vti1, and Gos1 SNAREs). Therefore,
Sed5 localization must be controlled such that it maintains a
steady-state distribution to the cis-Golgi (Hardwick and Pel-
ham, 1992; Wooding and Pelham, 1998), but nevertheless
can transverse the cisternae to interact productively with its
other SNARE partners or to be retrieved to the ER.
We propose that Sed5 transport and retrieval through the
Golgi is regulated by its phosphorylation state. The alanine
substitution mutant, whose expression results in an ordered
Golgi (Figures 4 and 5), and that efficiently incorporates into
COPI vesicles (Figure 6B), implies that enhanced Sed5 re-
trieval back through the cisternae might induce stacking.
This is supported by studies in sec21-2 cells, which are
defective in retrograde transport, and do not allow for for-
mation of ordered Golgi structures (Figure 7). However, we
do note that Sed5S317A colocalizes with Sec7, a trans-Golgi
marker, implying a steady-state presence in the trans-Golgi
(Figure 4D). This, as well, might account for the ordering
phenomenon and therefore requires further study. It is note-
worthy to add that stacking could also result from the ala-
nine mutant independently of its enhanced packaging into
COPI vesicles or retrograde transport. In contrast to
Sed5S317A, the aspartate substitution mutant, which is inef-
ficiently incorporated into COPI vesicles (Figure 6B) and
whose expression results in ER elaboration and vesicle ac-
Figure 8. Model for Golgi morphology as a consequence of Sed5
phosphorylation. Sed5 in its nonphosphorylated (at position 317)
state results in a stacked mammalian-like Golgi structure (Ordered
Golgi). In contrast, upon phosphorylation at position 317 Sed5
induces the dispersal of Golgi markers, the accumulation of trans-
port vesicles and ER, and inhibits cell growth (Dispersed Golgi).
Thus, Golgi structure may alternate between structured and un-
structured states as a consequence of t-SNARE phosphorylation.
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cumulation (Figure 5), may reside too efficiently in the cis-
compartment such that it inhibits retrograde transport
events and therefore cell growth (Figures 2 and 3). The
mechanism for Sed5 retention is also not well understood,
but previous studies suggested that it is determined by the
cytoplasmic domain and not by the TMD (Banfield et al.,
1994), in contrast to other SNAREs such as Snc1 (Lewis et al.,
2000). Serine-317, which is adjacent to the TMD, is therefore
a strong candidate for a Sed5 Golgi retention signal upon
phosphorylation.
Finally, we note that stacked Golgi-like structures have
been observed in other secretory mutants of S. cerevisiae;
however, these are seen at temperatures where Golgi export
is blocked (i.e., in sec7, sec14, and ypt31 ypt32-1 cells;
Novick et al., 1981; Franzusoff et al., 1991; Jedd et al., 1997),
whereas the ordered structures observed in Sed5S317A-ex-
pressing cells occur under conditions conducive for growth
(Figures 2 and 5). Thus, ordering per se has no deleterious
effects although the alanine mutant is not as effective for the
rescue of sed5-1 cells (Figure 2B). An ordered organization of
the Golgi, as seen in higher eukaryotes, may prove useful
where ER exit sites are more tightly controlled, leading to
the polarized accumulation of transitional ER (and subse-
quent Golgi coalescence). This may be of particular impor-
tance as cell size increases, allowing for more efficient trans-
port between cisternae as well as to target compartments.
The fact that a t-SNARE mutation can bring about such
morphological changes suggests that a controlled mecha-
nism for ordering and dispersal exists. This is likely to be
important for Golgi assembly and disassembly during the
mitotic cell cycle in higher eukaryotes, which also involves
cycles of protein phosphorylation and dephosphorylation.
In particular, the functioning of several Golgi structural
proteins (i.e., GM130, GRASP65, and p115) during mitosis
has been shown to be modulated by phosphorylation and in
a manner that correlates with Golgi fragmentation and dis-
persal (reviewed in Rossanese and Glick, 2001; Shorter and
Warren, 2002).
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